A Precision Medicine Approach to Target Engagement for Emotion Regulation
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Matthew Southward, PhD
- Study ID
- NCT05651295
- Status
- Recruiting
Conditions
- Anxiety
- Borderline Personality Disorder
- Depression
- Eating Disorders
- Emotional Regulation
- Obsessive-Compulsive Disorder
- Posttraumatic Stress Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Checking the Facts — BEHAVIORALChecking the Facts is a form of cognitive reappraisal in which participants identify negatively-valenced automatic thoughts and both generate and consider evidence that challenges the validity of those thoughts.
- Opposite to Emotion Action — BEHAVIORALOpposite to Emotion Action teaches participants to identify their momentary emotion(s), identify the associated behavioral urge(s), and implement a behavior inconsistent with that urge (e.g., approaching a feared stimulus instead of avoiding it).
- Mindfulness of Current Emotions — BEHAVIORALMindfulness of Current Emotions teaches participants to nonjudgmentally observe the experience of their emotions, including physiological and cognitive responses to those emotions.
Study Details
The proposed study is designed to first test whether teaching people personalized or standardized emotion regulation skills leads to greater decreases in daily negative emotion intensity. Second, using data from an initial sample, the investigators will prospectively assign an independent sample of participants to receive their predicted optimal or non-optimal skills to determine if it is feasible and efficacious to match participants to the most appropriate training condition. Results of these studies may identify the mechanisms by which emotion regulation interventions impact emotional functioning and allow for the development of personalized, evidence-based, and scalable emotion regulation interventions.
Key Dates
- Start date
- Sep 29, 2023
- Status verified
- May 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 390 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Personalized ConditionParticipants will learn one of three emotion regulation skills (i.e., cognitive restructuring, opposite to emotion action, mindfulness) that is their personal strength, based on pre-Baseline emotion regulation capacities. They will watch an interactive video, created for the current study, in which they are taught the skill that is their personal strength. They will also be asked to complete a survey during the video in which they will input their own examples to practice the skill and to ensure attention to and comprehension of the material.
- Active Comparator: Standardized ConditionParticipants will learn all three ER skills: cognitive restructuring, opposite to emotion action, and mindfulness. Participants will be asked to watch three interactive videos that cover each skill to provide an analogue to clinical practice in which clinicians must choose whether to provide greater breadth or depth of skill coverage. These videos will be presented in a randomized order and will include the same surveys for attention and comprehension used in the Personalized Condition.
Primary Outcome Measure
Changes in Positive and Negative Affect Schedule-Short Form [ Time Frame: 7 times per day for 42 days ]
Central Contacts
- Matthew W Southward, Ph.D.614-247-0331
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ohio State University | Columbus | Ohio | 43210 |
Find similar trials in Columbus, OH
Related Studies
- Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)PHASE4 · Recruiting · University of Cincinnati · Cincinnati, Ohio
- Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)PHASE4 · Recruiting · University of Cincinnati · Cincinnati, Ohio
- Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)PHASE4 · Recruiting · University of Cincinnati · Cincinnati, Ohio
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas